Skip to Content
Merck
  • miR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells.

miR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells.

Scientific reports (2015-08-12)
Xiaoyan Zhang, Xiao Han, Yuanjia Tang, Yanfang Wu, Bo Qu, Nan Shen
ABSTRACT

Renal mesangial cells (RMCs) constitute a population of cells in glomerular mesangium. Inflammatory cytokines produced by RMCs play a vital role in renal inflammation. miRNAs are key regulators of inflammatory cytokine expression. The abnormal expression of renal miRNAs and the consequent changes in inflammatory signal transduction are closely associated with renal inflammation. However, our knowledge of the functions of renal miRNAs is still limited. In this study, we investigated the role of miR-744 in type I interferon (IFN) signaling pathway in primary human RMCs. We show that overexpression of miR-744 enhances IFN-induced CCL2, CCL5, CXCL10, and IL6 expression specifically in RMCs. We found that the activation of TYK2, STAT1 and STAT3 was significantly enhanced by miR-744. miR-744 also enhanced the activation of non-classical signal components, such as ERK and p38. We then identified PTP1B, a ubiquitously expressed phosphatase, as the target of miR-744 that is responsible for enhancing type I IFN response. Finally, miR-744 expression was induced by type I IFN in RMCs. Collectively, our data indicate that by targeting PTP1B, miR-744 plays a feed-forward role in regulating type I IFN signaling pathway. These findings give us new insights into the functions of renal miRNAs in regulating important signaling pathways.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MISSION® esiRNA, targeting human PTPN1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Ptpn1
Sigma-Aldrich
DL-Tyrosine, 99%
Sigma-Aldrich
Luminol, 97%
Sigma-Aldrich
PD 98,059, solid
Sigma-Aldrich
Luminol, ≥97% (HPLC)